Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker

Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker

US Patent 7192724 · Granted Mar 20, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infe2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Fecal lactoferrin as a biomarker for determining disease severity and for treati2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2019
Nucleic acid extraction using organic solvents to remove inhibitors2016
Nucleic acid extraction using organic solvents to remove inhibitors2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Outer membrane protein 18 as a diagnostic marker for campylobacter2016
Compositions and methods for treating clostridium infection and preventing recur2016